In preclinical studies, spray offered nearly 100% protection from respiratory infections by COVID-19, influenza, viruses, and pneumonia-causing bacteria
Vaccines that might protect against COVID-19 have entered phase 3 trials — the last step before regular approval in humans — in record time, but the virus has moved faster, experts say.
The first study to examine life expectancy across more than 65,000 census tracts in the U.S. showed significant disparities within counties and states.
In a retrospective analysis of U.S. veterans 75 years or older, Harvard researchers found those who were prescribed statins had a 25 percent lower risk of death than their counterparts.
HMS alum and Boston Health Care for the Homeless Program founder Dr. Jim O’Connell has dedicated his life to helping the city’s most vulnerable citizens.
Researchers describe for the first time how relationships between different odors are encoded in the olfactory cortex, the region of brain responsible for processing smell.
Harvard public health experts said the U.S. coronavirus epidemic is getting “quite out of hand” and that lower death rates and younger populations testing positive should give no comfort.
As school officials worry about whether they can safely reopen their districts in the fall, Joseph Allen, a Harvard healthy buildings expert has an answer: yes.
As a result of COVID-19 shutdowns, a $15 billion loss in the primary care sector is expected to threaten practice viability, reducing further an already insufficient number of primary care providers in the United States.
A novel liquid biopsy method can detect kidney cancers with high accuracy, including small, localized tumors which are often curable but for which no early detection method exists.
A new Harvard Chan School study has found that pod-based e-cigarettes’ efficient delivery of nicotine may foster greater dependence than other types of e-cigarettes.
A Beth Israel Deaconess Medical Center study showed dramatic drops in hospital visits for heart attacks and stroke, which likely led to uncounted deaths at home during the COVID crisis. Perhaps more troubling is the potential for long-term damage to decades’ work to catch conditions in their earliest, most treatable stages.
Harvard-affiliated Beth Israel Deaconess Medical Center has developed vaccines — currently being tested in animal models — that are designed to train the body’s immune system to recognize the virus swiftly upon exposure and respond quickly to disable it.
A newly identified “metabolic signature” can evaluate an individual’s adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research led by Harvard T.H. Chan School of Public Health.
The Gazette asked alumni who are engaged in the battle against the novel coronavirus to share their experiences and how their work has radically changed.